CollPlant Acquires Lightsolver, Entering High-Performance Photonic Computing

Key Facts

In a move reflecting the trend of biotechnology firms diversifying into advanced technology sectors, CollPlant Biotechnologies announced the acquisition of Lightsolver. This acquisition is intended to provide CollPlant with a strategic entry point into the high-performance photonic computing (HPC) sector, representing a significant expansion of its business model. According to reports, the deal leverages Lightsolver's technology, which has already achieved real-world validation through collaboration with global leaders like Boeing.

This strategic pivot comes as mid-cap entities seek new growth engines through specialized M&A activity. Per market data, CLGN stock ended the session at $3.48 on September 16, 2026, having traded between a day low of $3.36 and a high of $3.56. CollPlant aims to utilize its position as a public company to provide the necessary capital and leadership to accelerate Lightsolver's journey toward full-scale commercialization.

Investors are now watching for the integration milestones of this photonic computing technology, with CLGN priced at $3.48 (close September 16, 2026). While the upcoming economic calendar does not list immediate catalysts for the company within the next week, the focus remains on future financial objectives and the commercial roadmap following this strategic acquisition.